SLN-12140

N/A

Report date: 2026/04/29 20:02:18

Base Information

Drug NameSLN-12140
Drug Alias NameSLN12140SLN-12140
ClassificationBiologics
Mechanisms of ActionComplement activation stimulants
TargetsNot applicable
Therapy Area/IndicationsComplement-Mediated DiseasesHemoglobinuria, ParoxysmalGlomerulonephritis, IGA
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Inactive CompaniesN/A
Active IndicationsComplement-Mediated DiseasesHemoglobinuria, ParoxysmalGlomerulonephritis, IGA
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A